Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder

2021 ◽  
Vol 105 ◽  
pp. 106394
Author(s):  
Nikhil Seval ◽  
Cynthia A. Frank ◽  
Alain H. Litwin ◽  
Prerana Roth ◽  
Meredith A. Schade ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Care Model ◽  
Disease Treatment ◽  
Randomized Controlled ◽  
Long Acting ◽  
Design And Methods

scholarly journals Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0183354 ◽  
Author(s):  
Phillip Oliver Coffin ◽  
Glenn-Milo Santos ◽  
Tim Matheson ◽  
Emily Behar ◽  
Chris Rowe ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
High Risk ◽  
Behavioral Intervention ◽  
Controlled Trial ◽  
Opioid Use Disorder ◽  
Opioid Overdose ◽  
Opioid Use ◽  
Randomized Controlled ◽  
Pilot Randomized Controlled Trial

Cognitive rehabilitation for individuals with opioid use disorder: A randomized controlled trial

2017 ◽  
Vol 29 (8) ◽  
pp. 1273-1289 ◽  
Author(s):  
Tara Rezapour ◽  
Javad Hatami ◽  
Ali Farhoudian ◽  
Mehmet Sofuoglu ◽  
Alireza Noroozi ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cognitive Rehabilitation ◽  
Controlled Trial ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Randomized Controlled

scholarly journals Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trial

2020 ◽  
Author(s):  
James S.H. Wong ◽  
Mohammadali Nikoo ◽  
Jean N. Westenberg ◽  
Janet G. Suen ◽  
Jennifer Wong ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Drug Use ◽  
Controlled Trial ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Induction Method ◽  
Open Label ◽  
Randomized Controlled ◽  
Parallel Group ◽  
Successful Induction

Background: Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and therefore experience withdrawal symptoms prior to induction, which can be a barrier in starting treatment. Rapid micro-induction (micro-dosing) involves the administration of small, frequent does of buprenorphine/naloxone and removes the need for a period of withdrawal prior to the start of treatment. This study aims to compare the effectiveness and safety of rapid micro-induction versus standard induction of buprenorphine/naloxone in patients with OUD. Methods: This is a randomized, open-label, two-arm, superiority, controlled trial comparing the safety and effectiveness of rapid micro-induction versus standard induction of buprenorphine/naloxone for the treatment of OUD. A total of 50 participants with OUD will be randomized at one Canadian hospital. The primary outcome is successful induction of buprenorphine/naloxone with low levels of withdrawal. Secondary outcomes are treatment retention, illicit drug use, self-reported drug use behaviour, craving, pain, physical health, safety, and client satisfaction. Discussion: This is the first randomized controlled trial to compare the effectiveness and safety of rapid micro-induction versus standard induction of buprenorphine/naloxone. This study will thereby generate evidence for a novel induction method which eliminates substantial barriers to the use of buprenorphine/naloxone in the midst of the ongoing opioid crisis.

scholarly journals Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: A randomized controlled trial.

2017 ◽  
Vol 85 (7) ◽  
pp. 689-701 ◽  
Author(s):  
Rebecca L. Schacht ◽  
Robert K. Brooner ◽  
Van L. King ◽  
Michael S. Kidorf ◽  
Jessica M. Peirce
Keyword(s):  
Randomized Controlled Trial ◽  
Prolonged Exposure ◽  
Controlled Trial ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document